Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Determining Specific Thyroid Transcripts in Peripheral Blood: A Single Center Study Experience.

T M, A E, O V, T T, D M, S R, H J, Z J.

Balkan J Med Genet. 2018 Dec 31;21(2):13-20. doi: 10.2478/bjmg-2018-0015. eCollection 2018 Dec.

2.

Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.

Milas M, Barbosa GF, Mitchell J, Berber E, Siperstein A, Gupta M.

Ann Surg Oncol. 2009 Feb;16(2):473-80. doi: 10.1245/s10434-008-0211-9. Epub 2008 Nov 18.

PMID:
19015922
3.

Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.

Chinnappa P, Taguba L, Arciaga R, Faiman C, Siperstein A, Mehta AE, Reddy SK, Nasr C, Gupta MK.

J Clin Endocrinol Metab. 2004 Aug;89(8):3705-9.

PMID:
15292293
4.

Correlation of thyroid stimulating hormone receptor mRNA expression levels in peripheral blood with undesirable clinicopathological features in papillary thyroid carcinoma patients.

Liu R, Hao S, Zhang H, Ma J, Liu X, Xu J, Liu X, Ning J, Sun Y, Jiang L, Li G, Song X, Zheng H.

Oncotarget. 2017 May 26;8(43):74129-74138. doi: 10.18632/oncotarget.18273. eCollection 2017 Sep 26.

5.
6.
7.

Renal expression of two 'thyroid-specific' genes: thyrotropin receptor and thyroglobulin.

Sellitti DF, Akamizu T, Doi SQ, Kim GH, Kariyil JT, Kopchik JJ, Koshiyama H.

Exp Nephrol. 2000 Jul-Oct;8(4-5):235-43.

PMID:
10940722
8.
9.

Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR.

Bojunga J, Röddiger S, Stanisch M, Kusterer K, Kurek R, Renneberg H, Adams S, Lindhorst E, Usadel KH, Schumm-Draeger PM.

Br J Cancer. 2000 May;82(10):1650-5.

10.

Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse.

Barzon L, Boscaro M, Pacenti M, Taccaliti A, Palù G.

Int J Cancer. 2004 Jul 20;110(6):914-20.

11.

Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.

Rinaldi S, Plummer M, Biessy C, Tsilidis KK, Østergaard JN, Overvad K, Tjønneland A, Halkjaer J, Boutron-Ruault MC, Clavel-Chapelon F, Dossus L, Kaaks R, Lukanova A, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Agnoli C, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Lund E, Quirós JR, Agudo A, Molina E, Larrañaga N, Navarro C, Ardanaz E, Manjer J, Almquist M, Sandström M, Hennings J, Khaw KT, Schmidt J, Travis RC, Byrnes G, Scalbert A, Romieu I, Gunter M, Riboli E, Franceschi S.

J Natl Cancer Inst. 2014 Jun;106(6):dju097.

PMID:
24824312
12.

Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.

Chia SY, Milas M, Reddy SK, Siperstein A, Skugor M, Brainard J, Gupta MK.

J Clin Endocrinol Metab. 2007 Feb;92(2):468-75. Epub 2006 Nov 21.

PMID:
17118994
13.

Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: diagnostic synergy for detecting thyroid cancer.

Wagner K, Arciaga R, Siperstein A, Milas M, Warshawsky I, Sethu S, Reddy K, Gupta MK.

J Clin Endocrinol Metab. 2005 Apr;90(4):1921-4. Epub 2005 Feb 1.

PMID:
15687333
14.

The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer.

Aliyev A, Soundararajan S, Bucak E, Gupta M, Hatipoglu B, Nasr C, Siperstein A, Berber E.

Surgery. 2015 Oct;158(4):1089-93; discussion 1093-4. doi: 10.1016/j.surg.2015.06.023. Epub 2015 Jul 23.

PMID:
26212344
15.

Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.

Denizot A, Delfino C, Dutour-Meyer A, Fina F, Ouafik L.

Thyroid. 2003 Sep;13(9):867-72.

PMID:
14588101
16.

Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas.

Gyftaki R, Liacos C, Politi E, Liontos M, Saltiki K, Papageorgiou T, Thomakos N, Haidopoulos D, Rodolakis A, Alevizaki M, Bamias A, Dimopoulos A.

Int J Gynecol Cancer. 2014 Jun;24(5):851-6. doi: 10.1097/IGC.0000000000000139. Erratum in: Int J Gynecol Cancer. 2015 Feb;25(2):336. multiple author names corrected.

PMID:
24844218
17.

Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.

Hesse E, Musholt PB, Potter E, Petrich T, Wehmeier M, von Wasielewski R, Lichtinghagen R, Musholt TJ.

Br J Cancer. 2005 Sep 5;93(5):565-70.

18.

Thyroglobulin mRNA expression in peripheral blood lymphocytes of healthy subjects and patients with thyroid disease.

Amakawa M, Kato R, Kameko F, Maruyama M, Tajiri J.

Clin Chim Acta. 2008 Apr;390(1-2):97-103. doi: 10.1016/j.cca.2008.01.007. Epub 2008 Jan 15.

PMID:
18243140
19.

Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples.

Milas M, Shin J, Gupta M, Novosel T, Nasr C, Brainard J, Mitchell J, Berber E, Siperstein A.

Ann Surg. 2010 Oct;252(4):643-51. doi: 10.1097/SLA.0b013e3181f5ba51.

PMID:
20881771
20.

Human fibrocytes coexpress thyroglobulin and thyrotropin receptor.

Fernando R, Atkins S, Raychaudhuri N, Lu Y, Li B, Douglas RS, Smith TJ.

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7427-32. doi: 10.1073/pnas.1202064109. Epub 2012 Apr 19.

Supplemental Content

Support Center